Skip to main content
. Author manuscript; available in PMC: 2018 Jul 31.
Published in final edited form as: J Acquir Immune Defic Syndr. 2016 Dec 15;73(5):556–563. doi: 10.1097/QAI.0000000000001143

Table 3.

Multivariable risk factors for number of sex partners in the past 30 days. TDF2 clinical trial, Botswana 2007–2010.

Characteristic No sex partners 1 or more sex partners
Odds
Ratio
95% CI p-value Rate
Ratio
95% CI p-value
Time (per year) 1.02 1.01, 1.03 <.0001 .97 .97, .98 <.0001
Treatment Arm
Perception
  TDF 0.92 0.68, 1.22 .5476 1.04 0.84, 1.29 .7328
  Not Sure 0.94 0.73, 1.20 .6008 1.02 0.85, 1.23 .8357
  Placebo REF REF
Marital Status
  Single REF -- -- --
  Married 0.33 0.17, 0.62 .0006 -- -- --
Age
  18–20 -- -- -- REF
  21–29 -- -- -- 3.12 1.18, 8.24 .0224
  30+ -- -- -- 2.14 0.75, 6.12 .1568
Occupational Status
  Employed 0.76 0.58, 1.00 .0467 -- -- --
  Unemployed REF -- -- --
Sexual Debut
  15 or less -- -- -- 2.92 2.01, 4.22 <.0001
  16–17 -- -- -- 2.34 1.69, 3.24 <.0001
  18–19 -- -- -- 1.23 0.91, 1.67 .1834
  20+ -- -- -- REF
Gender
  Female -- -- -- REF
  Male -- -- -- 3.67 2.86, 4.71 <.0001
STI
  Yes -- -- -- 1.79 1.34, 2.41 .0001
  No -- -- -- REF
HSV-2
  Yes 0.58 0.44, 0.76 .0001 -- -- --
  No REF -- -- --

Note: “--“ indicates the variable was not included in that component of the final multivariable model.